Skip to main content
How Altius® Works
Patient Stories
FAQ
About
Who we are
Management Team
Board of Directors
Technical Advisors
News
Contact Us
How Altius® Works
Patient Stories
FAQ
About
Who we are
Management Team
Board of Directors
Technical Advisors
News
Contact Us
News
The Latest about Neuros
Releases
Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation
Neuros Medical Receives FDA Approval for the Altius® Direct Electrical Nerve Stimulation System
Neuros Medical Strengthens Senior Leadership Team in Preparation for Commercialization of the Altius® System
Landmark Study of a Revolutionary Device for the Treatment of Post Amputation Pain Accepted for Publication in the Journal of Pain Research
Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints
Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System
Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical Appoints Tom Wilder as President and CEO
Neuros Medical Announces Closing of $20 Million Venture Financing